Covant Therapeutics
PrivateLast Round
Strategic
Mar 28, 2023
Total Funding Raised
$10M
Company Overview
Covant Therapeutics is a biotechnology company that develops novel oral covalent small molecules and long-acting injectable therapeutics for inflammation and immunology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Covant Therapeutics Comparables
Compare Covant Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nexo Therapeutics | 90% | |
| Hyku Biosciences | 89% | |
| Matchpoint Therapeutics | 82% |
Covant Therapeutics Funding Rounds
Historical fundraising activity
Covant Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Boehringer Ingelheim | Strategic |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 1, 2026
Monthly visitors grew 120% MoM.
- Jan 1, 2026
Monthly visitors grew 97% MoM.
Covant Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Covant Therapeutics's valuation, stock price, and market status.
Is Covant Therapeutics a public or private company?
Covant Therapeutics is a private company.
What is the current stock price of Covant Therapeutics?
Covant Therapeutics is a private company, so its shares have no public market price. Caplight tracks Covant Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Covant Therapeutics worth (valuation)?
Valuation information for Covant Therapeutics is not publicly available.
Can I buy Covant Therapeutics stock?
Covant Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Covant Therapeutics's last funding round?
Covant Therapeutics's most recent funding round was Strategic on March 28, 2023.
Who are the main investors in Covant Therapeutics?
Key investors in Covant Therapeutics include Boehringer Ingelheim.
Will Covant Therapeutics IPO soon?
No public IPO plans have been announced for Covant Therapeutics.
How can I track Covant Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Covant Therapeutics's shares on secondary markets.